Suven Life Sciences Ltd (SUVEN) Share Price Target Tomorrow| Prediction | Forecast for Intraday

loading widget to trade RELIGARE

The last closing price of SUVEN is 63.25 at 01-Dec-22 3:30:00 PM. We are providing SUVEN share price target on Intraday basis. These levels and targets calculated on the last 15mins candle. Current Support of SUVEN is 63.55 and Resistance is 63.8 on 15mins basis.

Live SUVEN share price target And Buy/Sell Levels

Last Updated at Last Price Buy Above Short Below
01-Dec-22 3:30:00 PM 63.25 63.8 63.55

For Intraday purpose:

Buying can be above 63.8 And SUVEN share price target can be 64.18, 64.57, 65.08

Shorting can be below 63.55 And SUVEN share price target can be 63.17, 62.79, 62.28

Click here for Best Shares to Buy
tomorrow for Intraday trading

This information is only for educational purpose, Please read carefully disclaimer of the website.

There is more information given below of the stock's detailed Technical analysis with the help of all indicators.

Technical Analysis of SUVEN

Last Updated at: 01-Dec-22 9:15:00 AM

Short Moving Average(21 Days)

SUVEN is Bullish on short moving average. Short moving average period is 21 Days.

Medium Moving Average(50 Days)

SUVEN is Bearish on Medium moving average. Medium moving average period is 50 Days.

Long Moving Average(100 Days)

SUVEN is Bearish on Long moving average. Medium moving average period is 100 Days.


SUVEN is Bullish on MACD indicator. MACD Stands for Moving Average Convergence Divergence.It is a trend following momentum indicator. For calculation three moving averages are taken which are 9 day EMA, 12 day EMA & 26 day EMA.


SUVEN is Bullish on Aroon indicator. The Aroon indicator is a technical indicator that is used to identify trend changes in the price of an asset, as well as the strength of that trend. In essence, the indicator measures the time between highs and the time between lows over a time period


SUVEN is Bearish on Stochastic indicator.

Bolinger Band

SUVEN is Neutral on Bolinger Band.
SUVEN Profile
Sector: Health Technology
Industry: Pharmaceuticals: Major
Employees: 142
Suven Life Sciences Ltd. engages on discovering, developing, and commercializing novel pharmaceutical products which are used in classic therapies. It operates through the following business segments: Drug Discovery & Development Support Services and Drug Discovery & Clinical/research pipe Line. The Drug Discovery & Development Support Services segment offers research services specializing in Synthetic, Medicinal and Analytical Chemistry, In-vitro Assay development and Screening, Drug Metabolism & Pharmacokinetics, CNS Pharmacology (Behavioral Pharmacology, Microdialysis, Receptor Occupancy, Electrophysiology), Toxicology and Safety Pharmacology, Bioanalysis, and NCE Formulations.The Drug Discovery & Clinical/research Pipe Line segment includes serotonin 6 receptor, serotonin 4 receptor, histamine 3 receptor, Nicotinic acetylcholine (Alpha4beta2) receptor, muscarinic M1 receptor, muscarinic M4 receptor, multimodal (Dopaminergic and seretonergic receptor) and P2X purinoceptor 7 receptor. The company was founded on March 9, 1989 and is headquartered in Hyderabad, India.